ARMCX5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.735400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.389400E-01
Normal-vs-Stage2
9.491000E-01
Normal-vs-Stage3
3.306400E-01
Normal-vs-Stage4
3.137000E-01
Stage1-vs-Stage2
1.652570E-01
Stage1-vs-Stage3
6.411900E-02
Stage1-vs-Stage4
9.049600E-01
Stage2-vs-Stage3
3.515600E-01
Stage2-vs-Stage4
2.059200E-01
Stage3-vs-Stage4
7.450000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.756200E-01
Normal-vs-AfricanAmerican
7.789800E-01
Normal-vs-Asian
8.489600E-01
Caucasian-vs-AfricanAmerican
7.365400E-01
Caucasian-vs-Asian
6.164600E-01
AfricanAmerican-vs-Asian
5.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.777000E-01
Normal-vs-Female
9.131600E-01
Male-vs-Female
5.938800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.746400E-01
Normal-vs-Age(41-60Yrs)
6.571800E-01
Normal-vs-Age(61-80Yrs)
8.859400E-01
Normal-vs-Age(81-100Yrs)
7.639600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.751600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.977400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.892800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.909900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.845640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.624000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.894200E-01
Normal-vs-Daily Drinker
8.329600E-01
Normal-vs-Weekly Drinker
6.396800E-01
Normal-vs-Occasional Drinker
4.157400E-01
Normal-vs-Social Drinker
8.837200E-01
Non Drinker-vs-Daily Drinker
9.334800E-01
Non Drinker-vs-Weekly Drinker
6.589800E-01
Non Drinker-vs-Occasional Drinker
2.047800E-02
Non Drinker-vs-Social Drinker
3.284600E-01
Daily Drinker-vs-Weekly Drinker
7.104200E-01
Daily Drinker-vs-Occasional Drinker
6.319900E-02
Daily Drinker-vs-Social Drinker
5.241200E-01
Weekly Drinker-vs-Occasional Drinker
3.453600E-02
Weekly Drinker-vs-Social Drinker
3.278800E-01
Occasional Drinker-vs-Social Drinker
2.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.281800E-02
Normal-vs-Grade 2
3.156700E-03
Normal-vs-Grade 3
1.538070E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.451600E-01
Grade 1-vs-Grade 3
9.261400E-01
Grade 1-vs-Grade 4
5.281800E-02
Grade 2-vs-Grade 3
5.139800E-01
Grade 2-vs-Grade 4
3.156700E-03
Grade 3-vs-Grade 4
1.538070E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.918600E-01
Normal-vs-NonDiabetic
9.402800E-01
Diabetic-vs-NonDiabetic
8.227600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.980200E-01
Normal-vs-NoPancreatitis
9.797000E-01
Pancreatitis-vs-NoPancreatitis
2.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.587400E-01
Normal-vs-N1
9.898200E-01
N0-vs-N1
8.141200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.832800E-01
Normal-vs-TP53-NonMutant
6.821800E-01
TP53-Mutant-vs-TP53-NonMutant
6.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
